Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Guardant Health, Inc. Transaction History
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
- $250 Billion
- Q3 2025
A detailed history of Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna transactions in Guardant Health, Inc. stock. As of the latest transaction made, Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna holds 10,800 shares of GH stock, worth $1.02 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
10,800
Previous 10,200
5.88%
Holding current value
$1.02 Million
Previous $531 Million
27.12%
% of portfolio
0.27%
Previous 0.21%
Shares
3 transactions
Others Institutions Holding GH
# of Institutions
450Shares Held
130MCall Options Held
2.04MPut Options Held
2.9M-
Vanguard Group Inc Valley Forge, PA11.9MShares$1.12 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$1.06 Billion0.01% of portfolio
-
Baillie Gifford & CO5.13MShares$484 Million0.25% of portfolio
-
Invesco Ltd. Atlanta, GA4.93MShares$465 Million0.05% of portfolio
-
Capital International Investors Los Angeles, CA4.69MShares$443 Million0.05% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $9.65B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...